Request for Covid-19 Impact Assessment of this Report
The United States Tianeptine market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Tianeptine market, reaching US$ million by the year 2028. As for the Europe Tianeptine landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Tianeptine players cover Servier, Lupin Limited, PharmaS, and Antibiotice, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Tianeptine market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
Patent
Generic
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.
Depression and Anxiety
Irritable Bowel Syndrome
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include
Servier
Lupin Limited
PharmaS
Antibiotice
Serdia Pharmaceuticals
Alvogen
Bausch Health
Genefar B.V.
Arena Pharmaceuticals
Glenmark
Novartis
Dongwha Pharm
Liconsa SA
Mylan
Adamed
Neuraxpharm Arzneimittel
Grupo Insud
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Tianeptine Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Tianeptine by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Tianeptine by Country/Region, 2017, 2022 & 2028
2.2 Tianeptine Segment by Type
2.2.1 Patent
2.2.2 Generic
2.3 Tianeptine Sales by Type
2.3.1 Global Tianeptine Sales Market Share by Type (2017-2022)
2.3.2 Global Tianeptine Revenue and Market Share by Type (2017-2022)
2.3.3 Global Tianeptine Sale Price by Type (2017-2022)
2.4 Tianeptine Segment by Application
2.4.1 Depression and Anxiety
2.4.2 Irritable Bowel Syndrome
2.5 Tianeptine Sales by Application
2.5.1 Global Tianeptine Sale Market Share by Application (2017-2022)
2.5.2 Global Tianeptine Revenue and Market Share by Application (2017-2022)
2.5.3 Global Tianeptine Sale Price by Application (2017-2022)
3 Global Tianeptine by Company
3.1 Global Tianeptine Breakdown Data by Company
3.1.1 Global Tianeptine Annual Sales by Company (2020-2022)
3.1.2 Global Tianeptine Sales Market Share by Company (2020-2022)
3.2 Global Tianeptine Annual Revenue by Company (2020-2022)
3.2.1 Global Tianeptine Revenue by Company (2020-2022)
3.2.2 Global Tianeptine Revenue Market Share by Company (2020-2022)
3.3 Global Tianeptine Sale Price by Company
3.4 Key Manufacturers Tianeptine Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Tianeptine Product Location Distribution
3.4.2 Players Tianeptine Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Tianeptine by Geographic Region
4.1 World Historic Tianeptine Market Size by Geographic Region (2017-2022)
4.1.1 Global Tianeptine Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Tianeptine Annual Revenue by Geographic Region
4.2 World Historic Tianeptine Market Size by Country/Region (2017-2022)
4.2.1 Global Tianeptine Annual Sales by Country/Region (2017-2022)
4.2.2 Global Tianeptine Annual Revenue by Country/Region
4.3 Americas Tianeptine Sales Growth
4.4 APAC Tianeptine Sales Growth
4.5 Europe Tianeptine Sales Growth
4.6 Middle East & Africa Tianeptine Sales Growth
5 Americas
5.1 Americas Tianeptine Sales by Country
5.1.1 Americas Tianeptine Sales by Country (2017-2022)
5.1.2 Americas Tianeptine Revenue by Country (2017-2022)
5.2 Americas Tianeptine Sales by Type
5.3 Americas Tianeptine Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Tianeptine Sales by Region
6.1.1 APAC Tianeptine Sales by Region (2017-2022)
6.1.2 APAC Tianeptine Revenue by Region (2017-2022)
6.2 APAC Tianeptine Sales by Type
6.3 APAC Tianeptine Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Tianeptine by Country
7.1.1 Europe Tianeptine Sales by Country (2017-2022)
7.1.2 Europe Tianeptine Revenue by Country (2017-2022)
7.2 Europe Tianeptine Sales by Type
7.3 Europe Tianeptine Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Tianeptine by Country
8.1.1 Middle East & Africa Tianeptine Sales by Country (2017-2022)
8.1.2 Middle East & Africa Tianeptine Revenue by Country (2017-2022)
8.2 Middle East & Africa Tianeptine Sales by Type
8.3 Middle East & Africa Tianeptine Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Tianeptine
10.3 Manufacturing Process Analysis of Tianeptine
10.4 Industry Chain Structure of Tianeptine
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Tianeptine Distributors
11.3 Tianeptine Customer
12 World Forecast Review for Tianeptine by Geographic Region
12.1 Global Tianeptine Market Size Forecast by Region
12.1.1 Global Tianeptine Forecast by Region (2023-2028)
12.1.2 Global Tianeptine Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Tianeptine Forecast by Type
12.7 Global Tianeptine Forecast by Application
13 Key Players Analysis
13.1 Servier
13.1.1 Servier Company Information
13.1.2 Servier Tianeptine Product Offered
13.1.3 Servier Tianeptine Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Servier Main Business Overview
13.1.5 Servier Latest Developments
13.2 Lupin Limited
13.2.1 Lupin Limited Company Information
13.2.2 Lupin Limited Tianeptine Product Offered
13.2.3 Lupin Limited Tianeptine Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 Lupin Limited Main Business Overview
13.2.5 Lupin Limited Latest Developments
13.3 PharmaS
13.3.1 PharmaS Company Information
13.3.2 PharmaS Tianeptine Product Offered
13.3.3 PharmaS Tianeptine Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 PharmaS Main Business Overview
13.3.5 PharmaS Latest Developments
13.4 Antibiotice
13.4.1 Antibiotice Company Information
13.4.2 Antibiotice Tianeptine Product Offered
13.4.3 Antibiotice Tianeptine Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 Antibiotice Main Business Overview
13.4.5 Antibiotice Latest Developments
13.5 Serdia Pharmaceuticals
13.5.1 Serdia Pharmaceuticals Company Information
13.5.2 Serdia Pharmaceuticals Tianeptine Product Offered
13.5.3 Serdia Pharmaceuticals Tianeptine Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 Serdia Pharmaceuticals Main Business Overview
13.5.5 Serdia Pharmaceuticals Latest Developments
13.6 Alvogen
13.6.1 Alvogen Company Information
13.6.2 Alvogen Tianeptine Product Offered
13.6.3 Alvogen Tianeptine Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 Alvogen Main Business Overview
13.6.5 Alvogen Latest Developments
13.7 Bausch Health
13.7.1 Bausch Health Company Information
13.7.2 Bausch Health Tianeptine Product Offered
13.7.3 Bausch Health Tianeptine Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 Bausch Health Main Business Overview
13.7.5 Bausch Health Latest Developments
13.8 Genefar B.V.
13.8.1 Genefar B.V. Company Information
13.8.2 Genefar B.V. Tianeptine Product Offered
13.8.3 Genefar B.V. Tianeptine Sales, Revenue, Price and Gross Margin (2020-2022)
13.8.4 Genefar B.V. Main Business Overview
13.8.5 Genefar B.V. Latest Developments
13.9 Arena Pharmaceuticals
13.9.1 Arena Pharmaceuticals Company Information
13.9.2 Arena Pharmaceuticals Tianeptine Product Offered
13.9.3 Arena Pharmaceuticals Tianeptine Sales, Revenue, Price and Gross Margin (2020-2022)
13.9.4 Arena Pharmaceuticals Main Business Overview
13.9.5 Arena Pharmaceuticals Latest Developments
13.10 Glenmark
13.10.1 Glenmark Company Information
13.10.2 Glenmark Tianeptine Product Offered
13.10.3 Glenmark Tianeptine Sales, Revenue, Price and Gross Margin (2020-2022)
13.10.4 Glenmark Main Business Overview
13.10.5 Glenmark Latest Developments
13.11 Novartis
13.11.1 Novartis Company Information
13.11.2 Novartis Tianeptine Product Offered
13.11.3 Novartis Tianeptine Sales, Revenue, Price and Gross Margin (2020-2022)
13.11.4 Novartis Main Business Overview
13.11.5 Novartis Latest Developments
13.12 Dongwha Pharm
13.12.1 Dongwha Pharm Company Information
13.12.2 Dongwha Pharm Tianeptine Product Offered
13.12.3 Dongwha Pharm Tianeptine Sales, Revenue, Price and Gross Margin (2020-2022)
13.12.4 Dongwha Pharm Main Business Overview
13.12.5 Dongwha Pharm Latest Developments
13.13 Liconsa SA
13.13.1 Liconsa SA Company Information
13.13.2 Liconsa SA Tianeptine Product Offered
13.13.3 Liconsa SA Tianeptine Sales, Revenue, Price and Gross Margin (2020-2022)
13.13.4 Liconsa SA Main Business Overview
13.13.5 Liconsa SA Latest Developments
13.14 Mylan
13.14.1 Mylan Company Information
13.14.2 Mylan Tianeptine Product Offered
13.14.3 Mylan Tianeptine Sales, Revenue, Price and Gross Margin (2020-2022)
13.14.4 Mylan Main Business Overview
13.14.5 Mylan Latest Developments
13.15 Adamed
13.15.1 Adamed Company Information
13.15.2 Adamed Tianeptine Product Offered
13.15.3 Adamed Tianeptine Sales, Revenue, Price and Gross Margin (2020-2022)
13.15.4 Adamed Main Business Overview
13.15.5 Adamed Latest Developments
13.16 Neuraxpharm Arzneimittel
13.16.1 Neuraxpharm Arzneimittel Company Information
13.16.2 Neuraxpharm Arzneimittel Tianeptine Product Offered
13.16.3 Neuraxpharm Arzneimittel Tianeptine Sales, Revenue, Price and Gross Margin (2020-2022)
13.16.4 Neuraxpharm Arzneimittel Main Business Overview
13.16.5 Neuraxpharm Arzneimittel Latest Developments
13.17 Grupo Insud
13.17.1 Grupo Insud Company Information
13.17.2 Grupo Insud Tianeptine Product Offered
13.17.3 Grupo Insud Tianeptine Sales, Revenue, Price and Gross Margin (2020-2022)
13.17.4 Grupo Insud Main Business Overview
13.17.5 Grupo Insud Latest Developments
14 Research Findings and Conclusion
Table 1. Tianeptine Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Tianeptine Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of Patent
Table 4. Major Players of Generic
Table 5. Global Tianeptine Sales by Type (2017-2022) & (K Units)
Table 6. Global Tianeptine Sales Market Share by Type (2017-2022)
Table 7. Global Tianeptine Revenue by Type (2017-2022) & ($ million)
Table 8. Global Tianeptine Revenue Market Share by Type (2017-2022)
Table 9. Global Tianeptine Sale Price by Type (2017-2022) & (US$/Unit)
Table 10. Global Tianeptine Sales by Application (2017-2022) & (K Units)
Table 11. Global Tianeptine Sales Market Share by Application (2017-2022)
Table 12. Global Tianeptine Revenue by Application (2017-2022)
Table 13. Global Tianeptine Revenue Market Share by Application (2017-2022)
Table 14. Global Tianeptine Sale Price by Application (2017-2022) & (US$/Unit)
Table 15. Global Tianeptine Sales by Company (2020-2022) & (K Units)
Table 16. Global Tianeptine Sales Market Share by Company (2020-2022)
Table 17. Global Tianeptine Revenue by Company (2020-2022) ($ Millions)
Table 18. Global Tianeptine Revenue Market Share by Company (2020-2022)
Table 19. Global Tianeptine Sale Price by Company (2020-2022) & (US$/Unit)
Table 20. Key Manufacturers Tianeptine Producing Area Distribution and Sales Area
Table 21. Players Tianeptine Products Offered
Table 22. Tianeptine Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Tianeptine Sales by Geographic Region (2017-2022) & (K Units)
Table 26. Global Tianeptine Sales Market Share Geographic Region (2017-2022)
Table 27. Global Tianeptine Revenue by Geographic Region (2017-2022) & ($ millions)
Table 28. Global Tianeptine Revenue Market Share by Geographic Region (2017-2022)
Table 29. Global Tianeptine Sales by Country/Region (2017-2022) & (K Units)
Table 30. Global Tianeptine Sales Market Share by Country/Region (2017-2022)
Table 31. Global Tianeptine Revenue by Country/Region (2017-2022) & ($ millions)
Table 32. Global Tianeptine Revenue Market Share by Country/Region (2017-2022)
Table 33. Americas Tianeptine Sales by Country (2017-2022) & (K Units)
Table 34. Americas Tianeptine Sales Market Share by Country (2017-2022)
Table 35. Americas Tianeptine Revenue by Country (2017-2022) & ($ Millions)
Table 36. Americas Tianeptine Revenue Market Share by Country (2017-2022)
Table 37. Americas Tianeptine Sales by Type (2017-2022) & (K Units)
Table 38. Americas Tianeptine Sales Market Share by Type (2017-2022)
Table 39. Americas Tianeptine Sales by Application (2017-2022) & (K Units)
Table 40. Americas Tianeptine Sales Market Share by Application (2017-2022)
Table 41. APAC Tianeptine Sales by Region (2017-2022) & (K Units)
Table 42. APAC Tianeptine Sales Market Share by Region (2017-2022)
Table 43. APAC Tianeptine Revenue by Region (2017-2022) & ($ Millions)
Table 44. APAC Tianeptine Revenue Market Share by Region (2017-2022)
Table 45. APAC Tianeptine Sales by Type (2017-2022) & (K Units)
Table 46. APAC Tianeptine Sales Market Share by Type (2017-2022)
Table 47. APAC Tianeptine Sales by Application (2017-2022) & (K Units)
Table 48. APAC Tianeptine Sales Market Share by Application (2017-2022)
Table 49. Europe Tianeptine Sales by Country (2017-2022) & (K Units)
Table 50. Europe Tianeptine Sales Market Share by Country (2017-2022)
Table 51. Europe Tianeptine Revenue by Country (2017-2022) & ($ Millions)
Table 52. Europe Tianeptine Revenue Market Share by Country (2017-2022)
Table 53. Europe Tianeptine Sales by Type (2017-2022) & (K Units)
Table 54. Europe Tianeptine Sales Market Share by Type (2017-2022)
Table 55. Europe Tianeptine Sales by Application (2017-2022) & (K Units)
Table 56. Europe Tianeptine Sales Market Share by Application (2017-2022)
Table 57. Middle East & Africa Tianeptine Sales by Country (2017-2022) & (K Units)
Table 58. Middle East & Africa Tianeptine Sales Market Share by Country (2017-2022)
Table 59. Middle East & Africa Tianeptine Revenue by Country (2017-2022) & ($ Millions)
Table 60. Middle East & Africa Tianeptine Revenue Market Share by Country (2017-2022)
Table 61. Middle East & Africa Tianeptine Sales by Type (2017-2022) & (K Units)
Table 62. Middle East & Africa Tianeptine Sales Market Share by Type (2017-2022)
Table 63. Middle East & Africa Tianeptine Sales by Application (2017-2022) & (K Units)
Table 64. Middle East & Africa Tianeptine Sales Market Share by Application (2017-2022)
Table 65. Key Market Drivers & Growth Opportunities of Tianeptine
Table 66. Key Market Challenges & Risks of Tianeptine
Table 67. Key Industry Trends of Tianeptine
Table 68. Tianeptine Raw Material
Table 69. Key Suppliers of Raw Materials
Table 70. Tianeptine Distributors List
Table 71. Tianeptine Customer List
Table 72. Global Tianeptine Sales Forecast by Region (2023-2028) & (K Units)
Table 73. Global Tianeptine Sales Market Forecast by Region
Table 74. Global Tianeptine Revenue Forecast by Region (2023-2028) & ($ millions)
Table 75. Global Tianeptine Revenue Market Share Forecast by Region (2023-2028)
Table 76. Americas Tianeptine Sales Forecast by Country (2023-2028) & (K Units)
Table 77. Americas Tianeptine Revenue Forecast by Country (2023-2028) & ($ millions)
Table 78. APAC Tianeptine Sales Forecast by Region (2023-2028) & (K Units)
Table 79. APAC Tianeptine Revenue Forecast by Region (2023-2028) & ($ millions)
Table 80. Europe Tianeptine Sales Forecast by Country (2023-2028) & (K Units)
Table 81. Europe Tianeptine Revenue Forecast by Country (2023-2028) & ($ millions)
Table 82. Middle East & Africa Tianeptine Sales Forecast by Country (2023-2028) & (K Units)
Table 83. Middle East & Africa Tianeptine Revenue Forecast by Country (2023-2028) & ($ millions)
Table 84. Global Tianeptine Sales Forecast by Type (2023-2028) & (K Units)
Table 85. Global Tianeptine Sales Market Share Forecast by Type (2023-2028)
Table 86. Global Tianeptine Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 87. Global Tianeptine Revenue Market Share Forecast by Type (2023-2028)
Table 88. Global Tianeptine Sales Forecast by Application (2023-2028) & (K Units)
Table 89. Global Tianeptine Sales Market Share Forecast by Application (2023-2028)
Table 90. Global Tianeptine Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 91. Global Tianeptine Revenue Market Share Forecast by Application (2023-2028)
Table 92. Servier Basic Information, Tianeptine Manufacturing Base, Sales Area and Its Competitors
Table 93. Servier Tianeptine Product Offered
Table 94. Servier Tianeptine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 95. Servier Main Business
Table 96. Servier Latest Developments
Table 97. Lupin Limited Basic Information, Tianeptine Manufacturing Base, Sales Area and Its Competitors
Table 98. Lupin Limited Tianeptine Product Offered
Table 99. Lupin Limited Tianeptine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 100. Lupin Limited Main Business
Table 101. Lupin Limited Latest Developments
Table 102. PharmaS Basic Information, Tianeptine Manufacturing Base, Sales Area and Its Competitors
Table 103. PharmaS Tianeptine Product Offered
Table 104. PharmaS Tianeptine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 105. PharmaS Main Business
Table 106. PharmaS Latest Developments
Table 107. Antibiotice Basic Information, Tianeptine Manufacturing Base, Sales Area and Its Competitors
Table 108. Antibiotice Tianeptine Product Offered
Table 109. Antibiotice Tianeptine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 110. Antibiotice Main Business
Table 111. Antibiotice Latest Developments
Table 112. Serdia Pharmaceuticals Basic Information, Tianeptine Manufacturing Base, Sales Area and Its Competitors
Table 113. Serdia Pharmaceuticals Tianeptine Product Offered
Table 114. Serdia Pharmaceuticals Tianeptine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 115. Serdia Pharmaceuticals Main Business
Table 116. Serdia Pharmaceuticals Latest Developments
Table 117. Alvogen Basic Information, Tianeptine Manufacturing Base, Sales Area and Its Competitors
Table 118. Alvogen Tianeptine Product Offered
Table 119. Alvogen Tianeptine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 120. Alvogen Main Business
Table 121. Alvogen Latest Developments
Table 122. Bausch Health Basic Information, Tianeptine Manufacturing Base, Sales Area and Its Competitors
Table 123. Bausch Health Tianeptine Product Offered
Table 124. Bausch Health Tianeptine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 125. Bausch Health Main Business
Table 126. Bausch Health Latest Developments
Table 127. Genefar B.V. Basic Information, Tianeptine Manufacturing Base, Sales Area and Its Competitors
Table 128. Genefar B.V. Tianeptine Product Offered
Table 129. Genefar B.V. Tianeptine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 130. Genefar B.V. Main Business
Table 131. Genefar B.V. Latest Developments
Table 132. Arena Pharmaceuticals Basic Information, Tianeptine Manufacturing Base, Sales Area and Its Competitors
Table 133. Arena Pharmaceuticals Tianeptine Product Offered
Table 134. Arena Pharmaceuticals Tianeptine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 135. Arena Pharmaceuticals Main Business
Table 136. Arena Pharmaceuticals Latest Developments
Table 137. Glenmark Basic Information, Tianeptine Manufacturing Base, Sales Area and Its Competitors
Table 138. Glenmark Tianeptine Product Offered
Table 139. Glenmark Tianeptine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 140. Glenmark Main Business
Table 141. Glenmark Latest Developments
Table 142. Novartis Basic Information, Tianeptine Manufacturing Base, Sales Area and Its Competitors
Table 143. Novartis Tianeptine Product Offered
Table 144. Novartis Tianeptine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 145. Novartis Main Business
Table 146. Novartis Latest Developments
Table 147. Dongwha Pharm Basic Information, Tianeptine Manufacturing Base, Sales Area and Its Competitors
Table 148. Dongwha Pharm Tianeptine Product Offered
Table 149. Dongwha Pharm Tianeptine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 150. Dongwha Pharm Main Business
Table 151. Dongwha Pharm Latest Developments
Table 152. Liconsa SA Basic Information, Tianeptine Manufacturing Base, Sales Area and Its Competitors
Table 153. Liconsa SA Tianeptine Product Offered
Table 154. Liconsa SA Tianeptine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 155. Liconsa SA Main Business
Table 156. Liconsa SA Latest Developments
Table 157. Mylan Basic Information, Tianeptine Manufacturing Base, Sales Area and Its Competitors
Table 158. Mylan Tianeptine Product Offered
Table 159. Mylan Tianeptine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 160. Mylan Main Business
Table 161. Mylan Latest Developments
Table 162. Adamed Basic Information, Tianeptine Manufacturing Base, Sales Area and Its Competitors
Table 163. Adamed Tianeptine Product Offered
Table 164. Adamed Tianeptine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 165. Adamed Main Business
Table 166. Adamed Latest Developments
Table 167. Neuraxpharm Arzneimittel Basic Information, Tianeptine Manufacturing Base, Sales Area and Its Competitors
Table 168. Neuraxpharm Arzneimittel Tianeptine Product Offered
Table 169. Neuraxpharm Arzneimittel Tianeptine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 170. Neuraxpharm Arzneimittel Main Business
Table 171. Neuraxpharm Arzneimittel Latest Developments
Table 172. Grupo Insud Basic Information, Tianeptine Manufacturing Base, Sales Area and Its Competitors
Table 173. Grupo Insud Tianeptine Product Offered
Table 174. Grupo Insud Tianeptine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 175. Grupo Insud Main Business
Table 176. Grupo Insud Latest Developments
List of Figures
Figure 1. Picture of Tianeptine
Figure 2. Tianeptine Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Tianeptine Sales Growth Rate 2017-2028 (K Units)
Figure 7. Global Tianeptine Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Tianeptine Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of Patent
Figure 10. Product Picture of Generic
Figure 11. Global Tianeptine Sales Market Share by Type in 2021
Figure 12. Global Tianeptine Revenue Market Share by Type (2017-2022)
Figure 13. Tianeptine Consumed in Depression and Anxiety
Figure 14. Global Tianeptine Market: Depression and Anxiety (2017-2022) & (K Units)
Figure 15. Tianeptine Consumed in Irritable Bowel Syndrome
Figure 16. Global Tianeptine Market: Irritable Bowel Syndrome (2017-2022) & (K Units)
Figure 17. Global Tianeptine Sales Market Share by Application (2017-2022)
Figure 18. Global Tianeptine Revenue Market Share by Application in 2021
Figure 19. Tianeptine Revenue Market by Company in 2021 ($ Million)
Figure 20. Global Tianeptine Revenue Market Share by Company in 2021
Figure 21. Global Tianeptine Sales Market Share by Geographic Region (2017-2022)
Figure 22. Global Tianeptine Revenue Market Share by Geographic Region in 2021
Figure 23. Global Tianeptine Sales Market Share by Region (2017-2022)
Figure 24. Global Tianeptine Revenue Market Share by Country/Region in 2021
Figure 25. Americas Tianeptine Sales 2017-2022 (K Units)
Figure 26. Americas Tianeptine Revenue 2017-2022 ($ Millions)
Figure 27. APAC Tianeptine Sales 2017-2022 (K Units)
Figure 28. APAC Tianeptine Revenue 2017-2022 ($ Millions)
Figure 29. Europe Tianeptine Sales 2017-2022 (K Units)
Figure 30. Europe Tianeptine Revenue 2017-2022 ($ Millions)
Figure 31. Middle East & Africa Tianeptine Sales 2017-2022 (K Units)
Figure 32. Middle East & Africa Tianeptine Revenue 2017-2022 ($ Millions)
Figure 33. Americas Tianeptine Sales Market Share by Country in 2021
Figure 34. Americas Tianeptine Revenue Market Share by Country in 2021
Figure 35. United States Tianeptine Revenue Growth 2017-2022 ($ Millions)
Figure 36. Canada Tianeptine Revenue Growth 2017-2022 ($ Millions)
Figure 37. Mexico Tianeptine Revenue Growth 2017-2022 ($ Millions)
Figure 38. Brazil Tianeptine Revenue Growth 2017-2022 ($ Millions)
Figure 39. APAC Tianeptine Sales Market Share by Region in 2021
Figure 40. APAC Tianeptine Revenue Market Share by Regions in 2021
Figure 41. China Tianeptine Revenue Growth 2017-2022 ($ Millions)
Figure 42. Japan Tianeptine Revenue Growth 2017-2022 ($ Millions)
Figure 43. South Korea Tianeptine Revenue Growth 2017-2022 ($ Millions)
Figure 44. Southeast Asia Tianeptine Revenue Growth 2017-2022 ($ Millions)
Figure 45. India Tianeptine Revenue Growth 2017-2022 ($ Millions)
Figure 46. Australia Tianeptine Revenue Growth 2017-2022 ($ Millions)
Figure 47. Europe Tianeptine Sales Market Share by Country in 2021
Figure 48. Europe Tianeptine Revenue Market Share by Country in 2021
Figure 49. Germany Tianeptine Revenue Growth 2017-2022 ($ Millions)
Figure 50. France Tianeptine Revenue Growth 2017-2022 ($ Millions)
Figure 51. UK Tianeptine Revenue Growth 2017-2022 ($ Millions)
Figure 52. Italy Tianeptine Revenue Growth 2017-2022 ($ Millions)
Figure 53. Russia Tianeptine Revenue Growth 2017-2022 ($ Millions)
Figure 54. Middle East & Africa Tianeptine Sales Market Share by Country in 2021
Figure 55. Middle East & Africa Tianeptine Revenue Market Share by Country in 2021
Figure 56. Egypt Tianeptine Revenue Growth 2017-2022 ($ Millions)
Figure 57. South Africa Tianeptine Revenue Growth 2017-2022 ($ Millions)
Figure 58. Israel Tianeptine Revenue Growth 2017-2022 ($ Millions)
Figure 59. Turkey Tianeptine Revenue Growth 2017-2022 ($ Millions)
Figure 60. GCC Country Tianeptine Revenue Growth 2017-2022 ($ Millions)
Figure 61. Manufacturing Cost Structure Analysis of Tianeptine in 2021
Figure 62. Manufacturing Process Analysis of Tianeptine
Figure 63. Industry Chain Structure of Tianeptine
Figure 64. Channels of Distribution
Figure 65. Distributors Profiles
The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...
The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...
The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...